Long QT syndrome
| Long QT syndrome | |
|---|---|
| ECG showing typical pattern of inherited Long QT syndrome (LQT1). A QT interval of >480 ms is considered abnormally long. | |
| Specialty | Cardiology |
| Symptoms | Fainting, hearing loss, seizures[1] |
| Complications | Sudden death[1] |
| Causes | Genetic, certain medications, low blood potassium, low blood calcium, heart failure[2] |
| Risk factors | Family history of sudden death[3] |
| Diagnostic method | Electrocardiogram (EKG), clinical findings, genetic testing [4][5] |
| Differential diagnosis | Brugada syndrome, arrhythmogenic right ventricular dysplasia[3] |
| Treatment | Avoiding strenuous exercise, getting sufficient potassium, beta blockers, implantable cardiac defibrillator[6] |
| Frequency | ≈ 1 in 7,000[6] |
| Deaths | ≈3,500 a year (U.S.)[6] |
Long QT syndrome (LQTS) is a condition affecting repolarization (relaxing) of the heart after a heartbeat, giving rise to an abnormally lengthy QT interval.[7] It results in an increased risk of an irregular heartbeat which can result in fainting, drowning, seizures, or sudden death.[1] These episodes can be triggered by exercise or stress.[6] Some rare forms of LQTS are associated with other symptoms and signs including deafness and periods of muscle weakness.[1]
Long QT syndrome may be present at birth or develop later in life.[1] The inherited form may occur by itself or as part of larger genetic disorder.[1] Onset later in life may result from certain medications, low blood potassium, low blood calcium, or heart failure.[2] Medications that are implicated include certain antiarrhythmics, antibiotics, and antipsychotics.[2] LQTS can be diagnosed using an electrocardiogram (EKG) if a corrected QT interval of greater than 450–500 milliseconds is found, but clinical findings, other EKG features, and genetic testing may confirm the diagnosis with shorter QT intervals.[4][5][8]
Management may include avoiding strenuous exercise, getting sufficient potassium in the diet, the use of beta blockers, or an implantable cardiac defibrillator.[6] For people with LQTS who survive cardiac arrest and remain untreated, the risk of death within 15 years is greater than 50%.[9][6] With proper treatment this decreases to less than 1% over 20 years.[3]
Long QT syndrome is estimated to affect 1 in 7,000 people.[6] Females are affected more often than males.[6] Most people with the condition develop symptoms before they are 40 years old.[6] It is a relatively common cause of sudden death along with Brugada syndrome and arrhythmogenic right ventricular dysplasia.[3] In the United States it results in about 3,500 deaths a year.[6] The condition was first clearly described in 1957.[10]
- ^ a b c d e f "Long QT syndrome". Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. 2017. Archived from the original on 14 December 2017. Retrieved 14 December 2017.
- ^ a b c Morita H, Wu J, Zipes DP (August 2008). "The QT syndromes: long and short". Lancet. 372 (9640): 750–63. doi:10.1016/S0140-6736(08)61307-0. PMID 18761222. S2CID 41181673.
- ^ a b c d Ferri FF (2016). Ferri's Clinical Advisor 2017 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 736. ISBN 9780323448383.
- ^ a b Cite error: The named reference
ESC 2015was invoked but never defined (see the help page). - ^ a b Cite error: The named reference
HRS guidelineswas invoked but never defined (see the help page). - ^ a b c d e f g h i j "Long QT Syndrome". NHLBI, NIH. Retrieved 14 December 2017.
- ^ Levine E, Rosero SZ, Budzikowski AS, Moss AJ, Zareba W, Daubert JP (August 2008). "Congenital long QT syndrome: considerations for primary care physicians". Cleveland Clinic Journal of Medicine. 75 (8): 591–600. doi:10.3949/ccjm.75.8.591 (inactive 12 July 2025). PMID 18756841. S2CID 4237579.
{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link) - ^ Afzal, Muhammad Adil; Khalid, Noman; Abdullah, Muhammad; ul-Haiy, Ata; Michael, Patrick (2023). "Hydroxyzine-Induced Torsade De Pointes: A Case Report and a Literature Review". Cureus. 15 (7): e41588. doi:10.7759/cureus.41588. ISSN 2168-8184. PMC 10407684. PMID 37559846.
- ^ Ackerman MJ, Priori SG, Dubin AM, Kowey P, Linker NJ, Slotwiner D, et al. (January 2017). "Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?". Heart Rhythm. 14 (1): e41 – e44. doi:10.1016/j.hrthm.2016.09.012. PMID 27659101.
Among patients who have experienced a LQTS-triggered cardiac event (arrhythmic syncope, arrhythmic syncope followed by seizures, or aborted cardiac arrest), the untreated natural history is grim, with >50% mortality at 15 years.
- ^ Vincent JL, Abraham E, Kochanek P, Moore FA, Fink MP (2011). Textbook of Critical Care E-Book. Elsevier Health Sciences. p. 578. ISBN 978-1437715682.